Corixa (company)
In today's world, Corixa (company) continues to be a topic of great relevance and interest to a wide spectrum of people. Whether due to its impact on society, politics or popular culture, Corixa (company) continues to generate debate and reflection in different areas. In this article we will explore the different aspects of Corixa (company), analyzing its importance, its implications and its possible future perspectives. Through a multidisciplinary approach, we seek to further understand the relevance of Corixa (company) today, as well as its potential influence on the future of contemporary society.
&sq=&lang=en&file=File:Question_book-new.svg){kind=small} | This article needs additional citations for verification. (July 2020) |
| This article relies largely or entirely on a single source. (July 2022) |
&sq=&lang=en&file=File:Corixa_logo.gif){kind=logo} | |
| Company type | biotechnology/pharmaceutical |
|---|---|
| Founded | 1994 in Seattle, Washington |
| Defunct | March 31, 2006 |
| Successor | acquired by GlaxoSmithKline |
| Headquarters | Seattle , Washington |
Number of locations | 2 |
| Parent | GlaxoSmithKline (United States)  |
Corixa was a biotechnology/pharmaceutical company based in Seattle, Washington, involved in the development of immunotherapeutics to combat autoimmune diseases, infectious diseases, and cancer. It was founded in 1994. It operated a laboratory and production facility in Hamilton, Montana.
In 2005, the European pharmaceuticals giant GlaxoSmithKline completed the acquisition of Corixa.[1] GSK had formerly made use of the Corixa's MPL (Monophosphoryl lipid A, a derivative of the lipid A molecule), an adjuvant in some of their vaccines.
External links
- "Corixa Corporation - powering the immune system". Archived from the original on 2006-03-01.
References
- ^ "Glaxo to acquire Corixa for $300 million". Market Watch. April 29, 2005.
47°36′58″N 122°20′03″W / 47.615976°N 122.334242°W
&sq=&lang=en&file=File:Factory.svg){kind=small} | This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Wikipedia by expanding it. |